ePreview 2

Pre-Conference Symposium I: There Will Be Blood

Your patient comes into the ER with a head trauma. Another presents with an intracranial hemorrhage due to hypertension. What are the best ways to manage and treat ICH? You can find out in Pre-Conference Symposium I of the AHA/ASA’s International Stroke Conference 2018.

“Stroke in the Real World: There Will Be Blood: Management and Treatment of ICH,” held on Jan. 23 in Room 151 at the Los Angeles Convention Center, will include presentations on:

  • Pre-hospital diagnosis and treatment
  • Emergency department stabilization and triage of the ICH patient
  • Understanding toxic clot constituents and cytotoxicity
  • A debate on minimally invasive surgery
  • How to investigate and image vascular lesions in ICH
  • Effects of size and ICH expansion
  • Amyloid angiopathy and microbleeds

Attendees also can participate in challenging breakout sessions and ask questions during an informal lunch with the faculty.

The symposium requires a separate fee to attend. Register now.

Symposium Schedule
9 a.m.
Welcome
Bruce Ovbiagele, MD, MSc, MAS, FAHA, Charleston, South Carolina

9:05 a.m.
“Scoop and Run: Pre-Hospital Diagnosis and Treatment of ICH”
Nerses Sanossian, MD, Los Angeles, California

9:20 a.m.
Q&A

9:30 a.m.
“The Golden Hour: ED Stabilization and Triage of the ICH Patient”
Opeolu Adeoye, MD, Cincinnati, Ohio

9:50 a.m.
Q&A

10 a.m.
“The Killing Fields: Toxic Clot Constituents and Cytotoxicity”
Guohua Xi, MD, Ann Arbor, Michigan

10:30 a.m.
Q&A

10:40 a.m.
“Double Indemnity: Surgery or Not? Minimally Invasive Surgery, Evidence and Debate” — Pro
Daniel F. Hanley, MD, FAHA, Baltimore, Maryland

10:55 a.m.
“Double Indemnity: Surgery or Not? Minimally Invasive Surgery, Evidence and Debate” — Con
Speaker TBD

11:10 a.m.
Q&A

11:20 a.m.
“Apocalypse Now: ICU Controversies: Where Is the Evidence?”
Navaz P. Karanjia, MD, San Diego, California

11:50 a.m.
Q&A

Noon-1 p.m.
Lunch

1 p.m.
“Lock, Stock and Two Barrels: Vascular Lesions in ICH? How to Investigate and Image”
Christian Stapf, MD, Montreal, Quebec, Canada

1:30 p.m.
Q&A

1:40 p.m.
“Larger Than Life: ICH Expansion and Size: Does the Size Matter?”
David Rodriguez-Luna, MD, PhD, Barcelona, Spain

2 p.m.
Q&A

2:10-2:55 p.m.
Concurrent IA (Room 502 A)
“The Ugly Truth: Practical Prognostication and Palliation: What Is the Evidence?”
Shouri Lahiri, MD, New York

Concurrent IB (Room 502 B)
“The Dark Knight: Complex Clinical Scenarios in ICH: When to Resume Anticoagulation”
Ashkan Shoamanesh, MD, Ancaster, Ontario, Canada

Concurrent IC (Room 515 A)
“Cloudy With a Chance of Meatballs: Role of Reversal Agents”

  • Role of Reversal Agents — Pro
    Patrick Lyden, MD, Los Angeles, California
  • Role of Reversal Agents — Con
    Dariush Dowlatshahi, MD, PhD, FRCPC, Ottawa, Ontario, Canada

3-3:45 p.m.
Concurrent IIA (Room 502 A)
“The Ugly Truth: Practical Prognostication and Palliation: What Is the Evidence?”
Shouri Lahiri, MD, New York

Concurrent IIB  (Room 502 B)
“The Dark Knight: Complex Clinical Scenarios in ICH: When to Resume Anticoagulation”
Ashkan Shoamanesh, MD, Ancaster, Ontario, Canada

Concurrent IIC (Room 515 A)
“Cloudy with a Chance of Meatballs: Role of Reversal Agents”

  • Role of Reversal Agents — Pro
    Patrick Lyden, MD, Los Angeles, California
  • Role of Reversal Agents — Con
    Dariush Dowlatshahi, MD, PhD, FRCPC, Ottawa, Ontario, Canada

4 p.m.
“Gorillas in the Mist: Congophilic Amyloid Angiopathy and Microbleeds: Diagnosis, Prognosis and Implications for Treatment”
Branko N. Huisa, MD, San Diego, California

4:30 p.m.
Q&A

4:40 p.m.
“Kramer vs. Kramer Debate: ‘Sweet Spot’ for Blood Pressure after ICH” — Pro Intense Therapy
Craig Anderson, MD, PhD, Sydney NSW, Australia

4:50 p.m.
“Kramer vs. Kramer Debate: ‘Sweet Spot’ for Blood Pressure after ICH” — Pro Moderate Therapy
Ken S. Butcher, MD, PhD, FRCP(C), Parkville Melbourne, Australia

5 p.m.
Q&A

5:05 p.m.
Gone in 60 Seconds: Closing Remarks
Bruce Ovbiagele, MD, MSc, MAS, FAHA, Charleston, South Carolina

Pre-Conference Symposium II: From Beside-to-Bench and Back Again

After four decades of investigating mechanisms involved in ischemic brain injury, we have yet to develop an FDA-approved neuroprotective agent. Is reversing translational research the answer?

You can explore this new paradigm in Pre-Conference Symposium II at the AHA/ASA’s International Stroke Conference 2018.

“Stroke in the Lab World: Reversing Stroke Translational Research — Bedside-to-Bench and Back Again” will be held on Jan. 23 in Theater 411 at the Los Angeles Convention Center. It will feature leading researchers who have successfully achieved reverse translation, starting with human samples and applying cutting-edge big data techniques to identify genes/proteins of relevance.

Attendees will further explore examples of next steps needed to understand molecular mechanisms implicated by the genes/proteins identified by these new -omic techniques.

There is a separate fee to attend. Register here.

Symposium Schedule
1 p.m.
“Failure of Traditional Forward Translation: The Case of Neuroprotection”
Jin-Moo Lee, MD, PhD, St. Louis, Missouri

1:15 p.m.
“Genomics Approach to Reverse Translation”
Daniel Woo, MD, Cincinnati, Ohio

1:55 p.m.
“Probing Biofluids to Understand Disease Pathogenesis: A Transcriptomics Approach”
Frank Ray Sharp, MD, Sacramento, California

2:35-2:45 p.m.
Break

2:45 p.m.
“Integrating Big Data Across the Omics: A Systems Biology Approach”
Philip De Jager, MD, New York

3:25 p.m.
“Bedside-to-Bench-to-Drug Target”
Martin Dichgans, MD, Munich, Germany

4:05 p.m.
“Harvesting Human Cells to Develop ‘Disease-in-a-Dish’”
Adam Engler, PhD, La Jolla, California

4:45 p.m.
Q&A

Don’t miss these industry events

You’ll participate in an array of sessions, interactive training and debates at the AHA/ASA’s International Stroke Conference 2018 on Jan. 24-26 at the Los Angeles Convention Center.

But there’s even more at ISC. Be sure to also check out Unofficial Satellite Events and Expert Theaters.

The events are independently organized by exhibitors, universities, nonprofits and industry supporters to provide prime opportunities to learn about the latest scientific advancements, and the theaters are settings to discover the newest products and services for stroke specialists.

Unofficial Satellite Events

Unofficial Satellite Events are not a part of the official International Stroke Conference planned by the ISC Program Committee.

Monday, Jan. 22
Time: 8 a.m.-5 p.m.
Title: Joint Cerebrovascular Section Annual Meeting
Location: Millennium Biltmore Hotel
Sponsored and supported by SNIS

Wednesday, Jan. 24
Time: 7-9 p.m.
Title: PFO Closure – Addressing the Unmet Need for Reducing the Risk of Recurrent Ischemic Stroke
Location: Sheraton Grand Los Angeles, Wiltern Room
Sponsored and supported by Abbott

Expert Theaters

Sessions in the Expert Theaters feature new stroke products and therapeutic treatments presented by industry supporters. The ASA will provide a complimentary lunch.

Wednesday, Jan. 24
Time: 12:10-12:40 p.m.
Title: Journey to ENRICH: The Evolutionary Trend Supporting Early Surgical Intervention for Intracerebral Hemorrhage
Speakers: Dr. Gustavo Pradilla, assistant professor of neurosurgery, Emory University School of Medicine, Atlanta, Georgia, and chief of neurosurgery service, Marcus Stroke & Neuroscience Center, Grady Health System, Atlanta, Georgia; Dr. Mark Bain, director of the Cerebrovascular Neurosurgery Fellowship Program, The Cleveland Clinic, Cleveland, Ohio
Supported by NICO Corp.

Thursday, Jan. 25
Time: 12:10-12:40 p.m.
Title: Cryptogenic Stroke — The Missing Linq
Speaker: Robert Felberg, MD, medical director, Overlook Hospital, Summit, New Jersey
Supported by Medtronic

Top